This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control and complications in diabetic subjects in Asia.
Study Type
OBSERVATIONAL
Enrollment
854
No treatment given
Novo Nordisk Investigational Site
Singapore, Singapore
Mean age of onset of type 1 and 2 diabetes mellitus
Time frame: at baseline visit/study start
Mean duration of treatment of type 2 DM
Time frame: at baseline visit/study start
Percentage of patients on Insulin and OAD therapy
Time frame: at baseline visit/study start
Mean duration of diabetes in type 1 and type 2 patients respectively
Time frame: at baseline visit/study start
Mean FPG and PPG of diabetic patients
Time frame: at baseline visit/study start
Mean HbA1c of diabetic patients
Time frame: at baseline visit/study start
Percentage of diabetic patients with HbA1c target below or equal to 7.0%
Time frame: at baseline visit/study start
Percentage of diabetic patients with HbA1c target below or equal to 6.5%
Time frame: at baseline visit/study start
Percentage of diabetic patients having dyslipidemia and hypertension
Time frame: at baseline visit/study start
Percentage of diabetic patients having cardiovascular complications
Time frame: at baseline visit/study start
Percentage of diabetic patients having peripheral vascular disease
Time frame: at baseline visit/study start
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Percentage of diabetic patients having diabetic nephropathy
Time frame: at baseline visit/study start
Percentage of diabetic patients having diabetic eye complications
Time frame: at baseline visit/study start
Patients' perception will be analysed through Patient questionnaire measuring - Psychological well-being, Quality of life, Patients' compliant to treatment
Time frame: at baseline visit/study start
Physician perception of diabetes and its management will be analysed through Physician questionnaire measuring awareness about - HbA1c test and its goal, Anti-diabetic treatment, Barriers towards optimum diabetes control
Time frame: at baseline visit/study start
Duration of diabetes associated with highest number of diabetic complications
Time frame: at baseline visit/study start
Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, Nephropathy and retinopathy)
Time frame: at baseline visit/study start